CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 4 Open-market buy Chairman and CEO bought 5,100 shares at an average $1.52 ($7,768)
- 4 Open-market buy Chairman and CEO bought 4,504 shares at an average $1.46 ($6,591)
- 8-K Event Other events
- NT 10-Q Other NT 10-Q
- 4 Open-market buy Chairman and CEO bought 12,800 shares at an average $1.22 ($15,659)
- 4 Open-market buy Vice Chairman & COO bought 14,850 shares at an average $1.10 ($16,395)
- 4 Open-market buy Chairman and CEO bought 6,000 shares at an average $1.20 ($7,180)
- 4 Open-market buy Vice Chairman & COO bought 4,000 shares at an average $1.25 ($4,995)
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- 8-K Event Material agreement · New debt or obligation
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 10-K Report Annual Report
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Auditor change
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement
- 4 Open-market buy Chairman and CEO bought 1,000 shares at $0.83 ($830)
- 4 Open-market buy Vice Chairman & COO bought 7,600 shares at an average $0.84 ($6,368)
Page 11 of 63 · 1,250 filings